ROSSO-in-praxi: A self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus

Diabetes Technology and Therapeutics

Volumn 12, Issue 7, 2010, Pages 547-553

  Kempf, Kerstin ^a   Kruse, Johannes ^b   Martin, Stephan ^a  

^a SANA KLINIKUM OFFENBACH   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEPRESSION; DIET THERAPY; EDUCATION PROGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MOTIVATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SELF MONITORING; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; WELLBEING; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 2; LIFESTYLE; METABOLISM; NONPARAMETRIC TEST; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIFE STYLE; QUALITY OF LIFE; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; WAIST CIRCUMFERENCE;

EID: 77954443657     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0008     Document Type: Article

References (18)

1. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-544.
2. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350. (Pubitemid 32378388)
3. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
4. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V: The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49: 289-297.
5. Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM, Curtis JM, Espeland MA, Foreyt JP, Graves K, Haffner SM, Harrison B, Hill JO, Horton ES, Jakicic J, Jeffery RW, Johnson KC, Kahn S, Kelley DE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montgomery B, Nathan DM, Patricio J, Peters A, Redmon JB, Reeves RS, Ryan DH, Safford M, Van Dorsten B, Wadden TA, Wagenknecht L, Wesche-Thobaben J, Wing RR, Yanovski SZ: Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007;30:1374-1383.
6. Clinical Guidelines Task Force: Global Guideline for Type 2 Diabetes. Brussels: International Diabetes Federation, 2005.
7. Hernan WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, Lachin JM, Engelgau MM: Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care 2003;26: 36-47. (Pubitemid 36928992)
8. National Institute for Health and Clinical Excellence: Quick Reference Guide Type 2 Diabetes. The Management of Type 2 Diabetes. London: National Health Service, 2008.
9. Poolsup N, Suksomboon N, Jiamsathit W: Systematic review of the benefit of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients. Diabetes Technol Ther 2008;10(Suppl 1):S-51-S-65.
10. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA: Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006;49:271-278.
11. Ware JE, Kosinski M, Keller SK: SF36 Physical and Mental Health Summary Scales: A User's Manual. Boston: The Health Institute, 1994.
12. Hautzinger M, Bailer M: ADS. Allgemeine Depressionsskala. Weinheim: Beltz, 1993.
13. O'Kane MJ, Bunting B, Copeland M, Coates VE: Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008;336:1174-1177.
14. Bullinger M, Kirchberger I, Ware J: Der deutsche SF-36 Health Survey. Z Gesundheitswiss 1995;3:21-36.
15. Bray G, Gregg E, Haffner S, Pi-Sunyer XF, Wagenknecht LE, Walkup M, Wing R: Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study. Diab Vasc Dis Res 2006;3: 202-215.
16. McAndrew L, Schneider SH, Burns E, Leventhal H: Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature. Diabetes Educ 2007; 33:991-1011.
17. Jones H, Edwards L, Vallis TM, Ruggiero L, Rossi SR, Rossi JS, Greene G, Prochaska JO, Zinman B: Changes in diabetes self-care behaviors make a difference in glycemic control: the Diabetes Stages of Change (DiSC) study. Diabetes Care 2003; 26:732-737.
18. Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmonth AL, Neil A: Impact of self monitoring of blood glucose in the management of patients with noninsulin treated diabetes: open parallel group randomised trial. BMJ 2007;335:132.